Race-Dependent Differences in Risk, Genomics, and Epstein-Barr Virus Exposure in Monoclonal Gammopathies: Results of SWOG S0120.

Madhav V DhodapkarRachael SextonAntje HoeringFrits Van RheeBart BarlogieRobert Z Orlowski

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)

These data provide the first prospective evidence that multiple myeloma precursor states in AA patients may have lower risk of disease compared with non-AA counterparts with lower incidence of high-risk GEP and increased EBV seropositivity. Race-dependent differences in biology and clinical risk of gammopathy may impact optimal management of these patients.

Keyphrases

epstein barr virus
end stage renal disease
newly diagnosed
ejection fraction
multiple myeloma
chronic kidney disease
diffuse large b cell lymphoma
prognostic factors
peritoneal dialysis
machine learning
patient reported outcomes
single cell